期刊文献+

散发性乳腺癌中BRCAl基因甲基化状况及其与蛋白表达的关系 被引量:2

Hypermethylation and expression of BRCAl gene in sporadic breast cancer patients
在线阅读 下载PDF
导出
摘要 目的探讨散发性乳腺癌中BRCA l基因异常甲基化状况及其与蛋白表达的关系,进而研究散发性乳腺癌中BRCA l基因异常的表遗传学作用。方法用甲基特异性聚合酶链反应(PCR)和免疫组织化学(SP)法研究乳腺癌组织、癌旁正常组织中BRCA l基因启动子甲基化状况及蛋白表达情况。结果在52例散发性乳腺癌中,BRCA l甲基化率为29%,BRCA l蛋白表达下降率为33%;15例BRCA l发生甲基化的癌组织标本中BRCA l的表达下降率为87%,而37例BRCA l未发生甲基化的癌组织中BRCA l蛋白表达下降率11%。在肿瘤分级中,T3分级患者的肿瘤组织中BRCA l甲基化率(45%)及表达下降率(60%)均分别高于T1+T2分级患者肿瘤组织的BRCA l甲基化率(19%)和表达下降率(16%);有淋巴结转移患者的肿瘤组织中BRCA l甲基化率(46%)及蛋白表达下降率(50%)均分别高于无淋巴结转移的甲基化率(14%)和表达下降率(18%)。结论BRCA l基因表遗传学改变是其蛋白表达下降乃至失活的重要原因,并且与散发性乳腺癌的恶性进程和淋巴结转移密切相关。 Objective To study the status of hypermethylated BRCA1 gene promoter regions and expression level of BRCA1 protein,and to research the epigenetics role of aberrant BRCA1 gene in sporadic breast cancer. Methods Methylation specific polymerase chain reaetion(PCR) was used to study the hypermethylation status of BRCA1 promoter regions and immunostaining was performed to analyze protein expression of BRCA1 in earcinous tissue and adjacent normal tissue of sporadic breast cancer. Results Hypermethylation frequencies of BRCA1 gene were 29% and reduced expression rates of BRCAI protein were 33% in 52 sporadic breast caneer; Reduced expression rates of BRCAI protein were 87% in 15 cases of malignant tissue which showed BRCA1 hypermethylated ,while there was only 11% reduced expression of BRCAI protein when BRCA1 gene kept unmethylated status in careinous tissue. Hypermethylation rates(45% ) of BRCAI and its expressional reducation rates (60%) of T3 tumor grade were higher than that of TI plus T2 tumor grades (19% and 16% ) respectively;Hypermethylation rates (46%) of BRCA1 gene and reduced expression rates (50%) of BRCA1 protein were also higher in the lymph node metastasis than thai of without lymph node metastasis ( 14% and 18%). Conclusions Epigenetics alterations of the BRCA1 gene can contribute to reducing or losing expression of BRCAI protein,which play an important role in the development of sporadic breast carcinoma and may be involved in lympth node metastasis.
出处 《检验医学》 CAS 北大核心 2006年第6期642-646,共5页 Laboratory Medicine
关键词 BRCA1基因 DNA甲基化 聚合酶链反应 甲基特异性 散发性乳腺癌 BRCAI gene DNA methylation polrmerase chain reaction Methylation specific Spoardic breast cancer
  • 相关文献

参考文献12

  • 1tterman JG, Graft JR, Myohancn S, et el. Methylationspecific PCR:a novel PCR assay for methylation status of CpG islands [ J]. Proc Nail Acid Sci USA,1996,93:9821-9826.
  • 2冯景,张吉才,陶建蜀,吕军,付萍,郭建华,周有利.散发性乳腺癌患者血浆BRCA1基因启动子异常甲基化的检测[J].中国癌症杂志,2005,15(5):442-445. 被引量:14
  • 3Esteller M, Silva JM, Dominguez G, et al. Prometer hypermethylation and BRCA1 inactivation in sporadic breast cencer and ovarian tumors [ J ]. J Natl Cancer Inst(Bethesda) 2000,92:564-569.
  • 4Futreal PA,LIU Q,Shattuck-Eidens D,et al. BRCA1 mutations in primary breast and ovarian carcinomas[ J ]. Science, 1994,266 : 120-122.
  • 5Cropp CS, Nevanlinna HA, Pyrhonen S, et al. Evidence for involvement of BRCA1 in sporadic breast carcinomas [ J ]. Cancer Res, 1994,54 : 2548-2551.
  • 6Carmen J,Isabel C, Paula M, et al. Detection of gene promoter hypermethylation in fine needle washing from broast lesions [ J ]. Clinical Cancer Res,2003,9 :3413-3417.
  • 7Caceres Ⅱ, Battagli C, Esteller M, el al. Tumor cellspecific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients [ J ]. Cancer Res,2004,64 : 6476-6481.
  • 8Catteau A, Harris WH, Xu CF, et al. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics [ J ]. Oncogene, 1999,18 : 1957-1965.
  • 9Esteller M, Corn PG, Baylin SB,et al. A gene hypermethylation profile of human cancer [ J ]. Cancer Res,2001,61:3225-3229.
  • 10Scully R, Canesan S, Drown M, et al. Location of BRCA1 in human breast and ovarian cancer cells [ J].Science, 1996,272 : 123-126.

二级参考文献13

  • 1Grady WM, Rajput A, Lutterbaugh JD, et al. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer[ J ]. Cancer Res, 2001,61 (3) :900-902.
  • 2Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands[ J ]. Proc Natl Acid Sci USA, 1996,93 ( 18 ) :9821-9826.
  • 3Siah SP, Quinn DM, Bennettt GD, et al. Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at "BAT25" and "BAT26" microsatellite markers in early onset breast cancer [ J ]. Breast Cancer Res Treat, 2000,60(2) :135-142.
  • 4Anbazhagan R, Fujii H, Gabrielson E. Microsatellite instability is unconnon in breast cancer [ J ]. Clinical Cancer Res, 1999,5(4) :839-844.
  • 5Silva JM, Donminguez G, Garcia JM, et al. Presence of tunor DNA in plasma of breast cancer patients:clinicopathological correlations [ J ]. Cancer Res, 1999,59 ( 13 ) :3251-3256.
  • 6Carmen J, Costa I, Conceic M,et al. Detection of gene promoter hypermethylation in fine needle washings from breast lesions [ J ].Clinical Cancer Res,2003,9 ( 9 ): 3413-3417.
  • 7Caceres I, Battagli C, Esteller M, et al. Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients [ J ]. Cancer Res,2004,64( 18 ) :6476-6481.
  • 8Bird AP. CpG-rich-island, and the function of DNA methylation[ J ]. Nature, 1986,321 ( 6067 ): 09-213.
  • 9Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patient: quantitation and evidence for their origin from apoptotic and necrotic cells [ J ]. Cancer Res,2001,61 (4): 1659-1665.
  • 10Stroun M, Maurice P, Vasioukhin V, et al. The origin and mechanism of circulating DNA [ J ]. Ann N Y Acad Sci ,2000,906(Apr) :161-168.

共引文献13

同被引文献13

  • 1朱瑞新,祝诗发,周俊红,陈敏伯.几个超分子体系中非常规键的AIM分析[J].化学学报,2006,64(3):191-197. 被引量:4
  • 2任婕,魏敏杰,金锋,杨栋,林哲珠,马文峰,金万宝.散发性乳腺癌组织中BRCA1基因启动子甲基化与蛋白表达的相关性[J].中华肿瘤防治杂志,2007,14(3):161-164. 被引量:12
  • 3宋依凝,魏敏杰,金万宝.乳腺癌易感基因(BRCA)生物学功能与临床与意义[J].现代肿瘤医学,2008,16(11):1992-1994.
  • 4Boukerroucha M, Josse C, Segers K, et al. BRCA1 germione mutation and glioblastoma development., report of cases[J]. BMC Cancer, 2015,15 : 181.
  • 5Chenevix-Treneh G, Healey S, Lakhani S, et al. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of an known clinical significance[J]. Cancer Res, 2006,66 (4) : 2019-2027.
  • 6Tae HK, Barrera L, Zheng M, et al. A high-resolution map of active promoters in the human genome[J]. Nature, 2005,436 (7052) : 876-880.
  • 7Michael W, Davies JJ, David W, et al. Chromosome-wide pro- moter-specific analyses identify sites of differential DNA meth- ylation in normal and transformed human eells[J].Nature Gen- et,2005,37(8) :853-862.
  • 8Ralhan R, Kaur J, Kreienberg R, et al. Links between DNA double strand break repair and breast cancer: accumulating ev- idence from both familial nonfamilial cases[J]. Cancer Lett,2007,248(1)1-17.
  • 9A1-Moghrabi N, Nofel A, AI-Yousef N, et al. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females[J].BMC Cancer, 2014,14(1) : 830.
  • 10Saelee P, Chaiwerawattana A, Oqawa K, et al. CIiniaopathogical significance of BRCA1 promoter hypermethylation in Thai breast cancer patients[J]. Asian Pac J Cancer Prev, 2014,15 (24) : 10585-10589.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部